Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer.

MLA

Shin, Dong Hoon, et al. “Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer.” Molecular Cancer Therapeutics, vol. 17, no. 9, Sept. 2018, pp. 2024–33. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-17-1178.

APA

Shin, D. H., Jo, J. Y., & Han, J.-Y. (2018). Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer. Molecular Cancer Therapeutics, 17(9), 2024–2033. https://doi.org/10.1158/1535-7163.MCT-17-1178

Chicago

Shin, Dong Hoon, Jeong Yeon Jo, and Ji-Youn Han. 2018. “Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer.” Molecular Cancer Therapeutics 17 (9): 2024–33. doi:10.1158/1535-7163.MCT-17-1178.